Pre-operative application of Teltivudine to improve hepatic function in patients with Primary hepatic cancer and positive HBV-DNA of low-concentration.

Trial Profile

Pre-operative application of Teltivudine to improve hepatic function in patients with Primary hepatic cancer and positive HBV-DNA of low-concentration.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2013

At a glance

  • Drugs Telbivudine (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date (31 Oct 2011) added as reported by Chinese Clinical Trial Register.
    • 21 Feb 2012 Status changed from recruiting to completed as reported by China Clinical Trials Register record.
    • 31 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top